Novartis Institute For Tropical Diseases (NVS) and Global Alliance For TB Drug Development Announce Five-Year Collaboration Targeted to Accelerate TB Treatment R&D

6/24/2008 9:23:23 AM

NEW YORK--(BUSINESS WIRE)--The Global Alliance for TB Drug Development (TB Alliance) and the Novartis Institute for Tropical Diseases (NITD) announced today a five-year research collaboration designed to yield new medicines for TB, including drug-resistant TB. The partnership is a milestone toward the development of faster TB drug regimens that treat all forms of TB, are easier for patients to complete, and can be used safely in patients with HIV/AIDS.

Read at BioSpace.com

Read Article at

Related Companies

News Categories

• BioSpace.com

• Global Alliance For TB Drug Development

• Novartis Institute For Tropical Diseases

• Biotech/Pharma - Alliances